Our findings demonstrated that serum total IgE levels were significantly higher in the lung cancer patients than in the healthy controls, and 47.9% of patients exhibited IgE levels exceeding 100 IU/ml (P < 0.01). This evidence concerns the gene IGHE and lung carcinoma.